(Q37257317)

19 August 2017

Pharmacokinetics and dose recommendations for cyclosporine and tacrolimus when coadministered with ABT-450, ombitasvir, and dasabuvir (English)

1 reference

19 August 2017

0 references

1 reference

1 reference

1 reference

P Badri

1

1 reference

19 August 2017

S Dutta

2

1 reference

19 August 2017

E Coakley

3

1 reference

19 August 2017

D Cohen

4

1 reference

19 August 2017

B Ding

5

1 reference

19 August 2017

T Podsadecki

6

1 reference

19 August 2017

B Bernstein

7

1 reference

19 August 2017

W Awni

8

1 reference

19 August 2017

R Menon

9

1 reference

19 August 2017

language of work or name

English

0 references

publication date

23 February 2015

1 reference

American Journal of Transplantation

19 August 2017

1 reference

19 August 2017

15

1 reference

19 August 2017

5

1 reference

19 August 2017

1313-1322

1 reference

Telaprevir with peginterferon/ribavirin for retreatment of null responders with advanced fibrosis post-orthotopic liver transplant

19 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5024008

Impact of OATP transporters on pharmacokinetics

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5024008

Management of hepatitis C virus in the transplant patient

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5024008

Scientific perspectives on drug transporters and their role in drug interactions

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5024008

Treatment of recurrent hepatitis C in liver transplant recipients

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5024008

Pathophysiology of hepatitis C virus infection and related liver disease

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5024008

Pharmacokinetics of tacrolimus-based combination therapies

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5024008

Mechanisms of clinically relevant drug interactions associated with tacrolimus

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5024008

Clinically significant drug interactions with cyclosporin. An update

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5024008

ABT-450/r-ombitasvir and dasabuvir with ribavirin for hepatitis C with cirrhosis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5024008

Treatment of HCV with ABT-450/r-ombitasvir and dasabuvir with ribavirin

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5024008

Telaprevir drug monitoring during antiviral therapy of hepatitis C graft infection after liver transplantation

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5024008

Safety and efficacy of protease inhibitors to treat hepatitis C after liver transplantation: a multicenter experience

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5024008

Exploratory study of oral combination antiviral therapy for hepatitis C.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5024008

Cyclosporine A- and tacrolimus-mediated inhibition of CYP3A4 and CYP3A5 in vitro

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5024008

Management of drug-to-drug interactions between cyclosporine A and the protease-inhibitor lopinavir/ritonavir in liver-transplanted HIV-infected patients

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5024008

Effect of coadministered lopinavir and ritonavir (Kaletra) on tacrolimus blood concentration in liver transplantation patients

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5024008

Effect of a single cyclosporine dose on the single-dose pharmacokinetics of sitagliptin (MK-0431), a dipeptidyl peptidase-4 inhibitor, in healthy male subjects

3 September 2018

1 reference

PubMed

12 December 2020

Effect of itraconazole on the concentrations of tacrolimus and cyclosporine in the blood of patients receiving allogeneic hematopoietic stem cell transplants

1 reference

PubMed

12 December 2020

Natural history of recurrent hepatitis C

1 reference

PubMed

12 December 2020

1 reference

12 December 2020

Identifiers

DOI

10.1111/AJT.13111

1 reference

release_dnuk46z7drfxfgibqf6lcqpsfm

19 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/dnuk46z7drfxfgibqf6lcqpsfm

24 November 2022

mapped directly with Wikidata item

1 reference

19 August 2017

PubMed publication ID

25708713

1 reference